News

See AroCell’s presentation at Stockholm Corporate Finance Life Science Capital Markets Days

Mar 24, 2023

On March 9, AroCell, Anders Hultman CEO, presented the latest developments and the future of the company at the Stockholm Corporate Finance Life Science Capital Markets Days at the IVA conference center in Stockholm.

Stockholm Corporate Finance arranged the capital market days for the fifteenth year in a row in collaboration with Financial Hearings and Infront Direkt Studios, which is an independent part of Nyhetsbyrån Direkt.
The presentation can be seen here: AroCell, and Direkt Studios interview.

Strategy update: IDL Diagnostics

A strategy update with IDL Diagnostics was held on November 27th at Redeye, where CEO Anders Hultman and the management team presented recent achievements, spotlighted key initiatives, and discussed future opportunities looking toward 2026 and beyond. After their...

read more

Thesis projects at IDL Diagnostics.

We are pleased to recognize four outstanding students who have recently completed their thesis projects with us at IDL Diagnostics. The projects started in January 2025. Putri Rezqita and Yu Shi from Karolinska Institutet contributed their deep knowledge in health and...

read more